<?xml version="1.0" encoding="UTF-8"?>
<ref id="b18-1031654">
 <label>18.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Wei</surname>
    <given-names>AH</given-names>
   </name>
   <name>
    <surname>Sadawarte</surname>
    <given-names>S</given-names>
   </name>
   <name>
    <surname>Catalono</surname>
    <given-names>J</given-names>
   </name>
  </person-group>
  <article-title>Phase Ib study combining mTOR inhibitor everolimus (RAD001) with low-dose cytarabine in untreated elderly AML</article-title>. 
  <source>Blood</source>. 
  <year>2010</year>;
  <volume>116</volume>(
  <issue>21</issue>):
  <fpage>3299</fpage>.
 </mixed-citation>
</ref>
